WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentations on Company and partner programs to be made at the upcoming American Association for Cancer Research (AACR) annual meeting to be held April 18-22, 2015 in Philadelphia, PA. These presentations will feature scientific data for ImmunoGen and partner ADCs as well as an array of ImmunoGen technology innovations.
Help employers find you! Check out all the jobs and post your resume.
